The global peptide therapeutics market is projected to grow at a significant CAGR of around 9.0% during the forecast period. Peptides are composed of short chains of amino acid monomers linked together via peptide bonds and occur naturally in the human body. Peptides are very specific in activity when compared to small molecules when used as a drug candidate. Generally having fewer side effects, peptides have become popular candidates for drug design. During the past decade, peptides have gained a wide range of applications in medicine and biotechnology, and therapeutic peptide research is also currently experiencing a renaissance for commercial reasons.

Free Sample Copy @ https://www.omrglobal.com/request-sample/peptide-therapeutics-market

The global peptide therapeutics market is geographically segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is estimated to contribute significantly to the market during the forecast period. The growth of the region is backed by several factors including the presence of advanced healthcare infrastructure in the region. Further, the presence of the key players, increasing prevalence of cancer, and the adoption of technologically advanced products in countries such as the US and Canada further give a boost to the regional growth of the market.

According to the American Cancer Society in 2017, it was estimated that there were 600,920 cancer deaths in the US. The Asia Pacific is projected to exhibit the fastest growth in the global peptide therapeutics market over the forecast period. This is mainly attributed to the developing healthcare infrastructure along with the increasing medical tourism in the economies such as India.

A Full Report of Global Peptide Therapeutics Market is Available at:
https://www.omrglobal.com/industry-reports/peptide-therapeutics-market

The primary factor that drives the growth of the market include the incidences of cancer along with other metabolic disorders across the globe. Additionally, the rising demand for cost-efficient and effective drugs, along with the rapid R&D activities in order to manufacture novel drugs for the treatment are also likely to contribute to the growth of the market during the forecast period.

However, limitations linked with the peptides, inadequate resources, and stringent regulations by the government are some of the factors that may challenge the growth of the market during the forecast period. Nevertheless, the presence of the key players continuously contributing to the growth of the market along with numerous government initiatives to successfully detect and treat cancer, which is providing opportunities for the growth of the market growth.

Global Peptide Therapeutics Market – Segmentation
by Route of Administration
Oral
Parenteral
by Application
Cancer
Gastrointestinal Disorders
Central Nervous System Disorders
Respiratory Disorders
Others
Global Peptide Therapeutics Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Amgen, Inc.
AstraZeneca Plc
Bachem Holding AG
Bristol-Myers Squibb Co.
CordenPharma InternationalGmbH
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Lonza Group AG
Merck & Co. Inc.
Novartis International AG
Novo Nordisk A/S
Pfizer, Inc.
PolyPeptide Group
Sanofi SA
Takeda Pharmaceutical Co. Ltd.
Teva Pharmaceuticals Industries Ltd.
Xenetic Biosciences, Inc..

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/peptide-therapeutics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404